What issues should be considered for the study population and recruitment, particularly in relation to Good Clinical Practice (GCP) certification?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The correct answer is B. Eligibility and vulnerable populations. When considering study populations and recruitment for clinical trials, researchers must carefully define eligibility criteria that specify who can participate in the study. These criteria must be scientifically justified and ethically sound. Special attention must be given to vulnerable populations such as children, pregnant women, prisoners, mentally disabled persons, or economically disadvantaged individuals who may require additional protections. Good Clinical Practice (GCP) guidelines emphasize the importance of fair selection of participants based on scientific objectives rather than convenience, while ensuring that vulnerable groups are neither inappropriately included nor excluded from research 1. Proper consideration of eligibility and vulnerable populations helps maintain the ethical integrity of clinical research by balancing scientific validity with participant protection. Some key considerations for study population and recruitment include:

  • Defining clear eligibility criteria that are scientifically justified and ethically sound
  • Ensuring fair selection of participants based on scientific objectives rather than convenience
  • Protecting vulnerable populations from exploitation or harm
  • Promoting participant inclusivity by addressing barriers to participation, such as access to technology, language, and cultural requirements 1. Additionally, researchers should provide a clear description of the study population, including patient characteristics, eligibility criteria, and exclusion criteria, to place the study in a clinical context 1.

From the Research

Issues of Consideration for Study Population and Recruitment

  • The correct answer is B. Eligibility and vulnerable populations.
  • Issues of consideration for study population and recruitment include eligibility and vulnerable populations 2, 3, 4, 5, 6.
  • Eligibility criteria are used to determine which individuals are suitable to participate in a study, and vulnerable populations, such as children, pregnant women, and prisoners, require special consideration to ensure their rights and welfare are protected.
  • The principles of good clinical practice (GCP) emphasize the importance of ensuring that the rights, safety, and well-being of trial participants are protected, and that the trial is conducted in accordance with the principles of GCP and applicable regulatory requirements.
  • Some of the key considerations for study population and recruitment include:
    • Informed consent: ensuring that participants understand the purpose, risks, and benefits of the study
    • Eligibility criteria: determining which individuals are suitable to participate in the study
    • Vulnerable populations: taking special precautions to protect the rights and welfare of vulnerable populations
    • Recruitment strategies: using appropriate methods to recruit participants, such as advertising, social media, and community outreach
    • Diversity and representation: ensuring that the study population is diverse and representative of the target population.

References

Related Questions

What type of studies are conducted to examine the long-term safety of a drug after it has been approved for marketing by the Food and Drug Administration (FDA)?
What personnel may be included in the staff at a research site, such as Research Assistants (RAs), Therapists/Counselors, or the Principal Investigator (PI)?
Are researchers required to maintain confidentiality even if a participant commits a crime?
What is the required timeframe for site staff to report an unexpected serious adverse event (SAE) to the Sponsor after becoming aware of the event?
What types of study visits do protocol monitors conduct at research sites, including For Cause, Closeout, Interim, and Initiation visits, for Good Clinical Practice (GCP) certification?
What substances cross-react with barbiturates (barbituric acid derivatives) on drug tests?
Which arteries supply arteriovenous malformations (AVMs) of the face?
What is the molecular pathophysiological explanation for the loss of salt (hyponatremia with hyperkalemia) in 21-hydroxylase (21-Hydroxylase) deficiency, versus the gain of salt (hypernatremia with hypokalemia) in 11-beta hydroxylase (11-beta Hydroxylase) deficiency, despite the latter producing a weak mineralocorticoid?
What is the recommended duration to stop clopidogrel (Plavix) (antiplatelet medication) before undergoing a polypectomy (removal of a polyp)?
What key principles of human research protections did the Belmont Report of 1979 establish?
What central roles are involved in the conduct of a research study: Sponsor (Sponsor) or Principal Investigator (Principal Investigator)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.